Drugs / 111-In capromab pendetide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00992745 | Oct 2009 → Sep 2011 | prostate cancer | Molecular Insight Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 111-In capromab pendetide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00992745 ↗ |
| Route | Intravenous | “Single 5 mCi intravenous injection” NCT00992745 ↗ |